Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Ain Shams University

Status and phase: Completed; Phase 3

Conditions: Placenta Previa

Treatments: Drug: Tranexamic acid

Study type: Interventional

Funder types: Other

Identifiers

NCT03060889

AAbdelaziz

Details and patient eligibility

About

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Full description

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Enrollment: 86 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Term pregnancy (more than 37 weeks of gestation)
• Diagnosis of placenta previa was confirmed by ultrasound
• The patient hemoglobin percentage is more than 10 mg/dl

Exclusion criteria

• Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies
• Emergency lower segment cesarean section
• Associated medical comorbidities

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

86 participants in 2 patient groups

Cases

Active Comparator group

Description:

Tranexamic acid 10 mg/ kg body weight will be given by intravenous infusion with induction of anesthesia in elective cesarean section for non complicated cases of placenta previa

Treatment:

Drug: Tranexamic acid

Controls

No Intervention group

Description:

Control group will not receive Tranexamic acid